Research Notes

Stay informed with the most recent market and company research insights.

A man sitting at a table with a glass of orange juice.

Research Notes

DisloCATion

Johns Lyng Group
3:27pm
February 27, 2024
JLG’s delivered a reasonable 1H24 result, Group EBITDA (excl. Commercial construction impacts) of $69.7m, +8% yoy (~7% ahead of MorgF). Within this result BAU EBITDA was in-line with our forecast, with the beat driven by improved CAT EBITDA (-27% following a 1H23 record) UNPAT of $25.9m was +1% yoy. JLG’s FY24 Group EBITDA (Ex. CC) guidance was upgraded 5% to 136.5m, (driven by improved CAT earnings outlook). We trim our EPS by ~3% in FY24-FY26F, we retain our Add rating with a revised price target to $7.30ps.

Tempting to throw the baby out with the bath water

DGL Group
3:27pm
February 27, 2024
DGL delivered a weak 1H24, with NPAT declining 41% on the pcp, well below both our expectations and consensus. Whilst an element of the performance is cyclical, company guidance sees only modest improvement in 2H24, with the company forecasting FY24 NPAT to decline on the pcp. In discussing the result, management talked about investing for growth, expensing costs where possible, to allow the company to grow organically in years to come – something that comes at the cost of current P&L earnings. Whilst the narrative resonates, it isn’t lost on us that the predictability of DGL’s earnings continues to decline – DGL is likely to grow slower than we expected, with earnings more cyclical. It is on this basis that we apply a lower multiple to lower earnings, whilst retaining our Add recommendation on a lower target price of $0.77/sh.

Managing softer conditions well

Reece
3:27pm
February 27, 2024
REH’s 1H24 result was above expectations with earnings growth delivered in both ANZ and the US despite subdued macroeconomic conditions. Key positives: Group EBITDA margin increased 60bp to 11.6% with margins higher in both regions; ROCE rose 80bp to 16.1%; Balance sheet remains healthy with ND/EBITDA falling to 0.7x (FY23: 0.9x). Key negative: Demand remains subdued with management expecting a softening environment in ANZ in 2H24. We increase FY24-26F EBITDA by between 10-12%. Our target price increases to $22.10 (from $15.50) on the back of updates to earnings forecasts and a roll-forward of our model to FY25 forecasts. With a 12-month forecast TSR of -22%, we retain our Reduce rating. We continue to see REH as a good business with a strong brand and a long-term track record of investment for growth. However, trading on 41.9x FY25F PE and 1.0% yield, we think the stock is overvalued in the short term, especially relative to our growth forecast (3-year EPS CAGR of 5%).

Supermarkets performing well

Coles Group
3:27pm
February 27, 2024
COL’s 1H24 results was above expectations driven mainly by the core Supermarkets segment. Key positives: Supermarkets Own Brand sales increased 7.6% with eCom sales jumping 29.2%; Investments to reduce total loss saw an improvement in loss through 2Q24 with expectations for further benefits in 2H24; Supermarkets sales growth of 4.9% in early 2H24 was well above Woolworths’ (WOW) Australian Food growth of ~1.5%. Key negatives: Liquor earnings were below our forecast; Group EBIT margin fell 30bp to 4.8%. Following the better-than-expected 1H24 result and solid start to 2H24, we increase FY24-26F underlying EBIT by between 3-4%. This reflects upgrades to Supermarkets earnings forecasts, partially offset by downgrades to Liquor. Our target price rises by $18.70 (from $16.60) on the back of updates to earnings forecasts and a roll-forward of our model to FY25 forecasts. We maintain our Add rating with COL being our preference in the Consumer Staples sector.

Topline headwinds remain but margins improving

Articore
3:27pm
February 27, 2024
Articore Group’s (ATG) 1H24 marketplace revenue (MPR) was ~5% under consensus at ~A$260m (-13% on pcp on a constant currency basis) but broadly in line with consensus at GPAPA (~A$64m, +19% on pcp). Whilst management initiatives around improving the margin profile of the business appear on track, we note ATG expects the softer consumer environment to persist into the 2H and hence topline growth eludes at this juncture. We make several adjustments to our medium-term forecasts, predominantly related to: 1) the lower marketplace revenue environment; and 2) the narrowed FY24 margin guidance (details below). Our price target is altered marginally to A$0.70 from (A$0.71). Hold maintained.

1H in line- Working on a “step-change” in core ops

Healius
3:27pm
February 27, 2024
1H results were pre-released so in line, with underlying Op income falling by double-digits and margins compressing. Pathology was the main drag, negatively impacted by cycling out of covid-19 testing, combined with low volumes and cost inflation, while Lumus Imaging was “ahead of target” on strength in the hospital and community segments, and Agilex showed “positive signs” on increasing new contracts. While management is accelerating Pathology restructuring to better match volumes with costs, aiming for a “step-change” by FY26/27, uncertainty around the impact of numerous initiatives make forecasting challenging and unreliable. We lower our FY24-26 estimates, with our target price decreasing to A$1.32. Hold

Execution on point

SiteMinder
3:27pm
February 27, 2024
1H24 underlying EBITDA/NPAT was below MorgansF and consensus. Subscribers, revenue, and cashflow were pre-released at SDR’s 2Q24 update. The highlight for us was SDR continuing to demonstrate ongoing improvement in its profitability and unit economics whilst maintaining solid growth momentum. Management said the 2H24 has started well and reiterated FY24 guidance for positive underlying EBITDA and FCF in 2H24. SDR continues to target medium-term organic revenue growth of 30%. We continue to think SDR offers an attractive long-term growth opportunity underpinned by its global underpenetrated TAM and opportunity to better monetise its A$70bn of Gross Booking Value (currently captures ~0.2%). ADD maintained.

Growing across all regions

Polynovo
3:27pm
February 27, 2024
PNV posted its 1H24 results which was in line with our forecasts. Sales momentum across all regions is continuing and we have upgraded our sales forecasts which sees average growth of 32% pa over the next three years. As a result of upgrades to forecasts our TP has increased to A$2.22, and with >10% upside to the target we upgrade our recommendation to Add (from Hold).

Improving profitability but some top-line headwinds

Tyro Payments
3:27pm
February 27, 2024
TYR’s 1H24 normalised gross profit (A$105m) was +~11% on the pcp and in-line with consensus (A$105m), whilst the 1H24 normalised EBITDA (A$27m, +41% on the pcp) was slightly below consensus (-3%).  While 1H24 showed good overall profitability trends, in our view, some issues with the Bendigo Alliance and a tougher core business transaction environment point to a softer top-line outlook in 2H24. We reduce our TYR FY24F/FY25F EBITDA figures by -6%-12% mainly on lower transaction value forecasts. While our EPS estimates in FY24F rise on lower share-based payments, FY25F EPS declines by -13%. Our PT is set at A$1.47 (previously A$1.61). We see recent improvements in TYR’s underlying operating performance as encouraging, and think there remains long-term value in the name. ADD.

1H24 result: Not flying yet, but the bags are packed

Aerometrex
3:27pm
February 27, 2024
AMX has released its 1H report in-line with our expectations. Key focus remains on Annual Recurring Revenue (ARR) growth and cost controls, both improving over the last 12 months. LiDAR growth continues to grab the headlines, but we’re getting the sense MetroMap is back on track with the worst now behind it following a number of years contending with competitive pressures and aviation constraints. We retain an Add recommendation on AMX and continue to see an attractive risk/reward profile with clearer skies ahead. Our valuation and target price increases marginally to A$0.50 p/s (from A$0.45 p/s).

News & Insights

Investment Watch is a flagship product that brings together our analysts' view of economic and investment strategy themes, sector outlooks and best stock ideas for our clients.

Investment Watch is a quarterly publication produced by Morgans that delves into key insights for equity and economic strategy. This latest publication will cover;

  • Asset Allocation – not the time to play defence
  • Economic Strategy – averting a world recession
  • Equity Strategy – attention turns to August
  • Resources & Energy – domestic gas coming to the boil
  • Banks – befuddling
  • Updated Morgans Best Ideas

Morgans clients receive exclusive insights such as access to our latest Investment Watch publication. Download the preview now.

      
View Investment Watch
      

Preview

We think the investment landscape remains favourable. The US economic fundamentals are strong with no significant downside risks to growth in the near-term. European leading indicators suggest a turning point is near and China’s cyclical recovery is still gaining momentum after bottoming earlier in the year.

Meanwhile, the Australian economy continues to defy expectations of a sharper slowdown. In our view, this is not the time to play defence and continue to expect growth assets such as equities and property to do well. This quarter, we look at tactical opportunities in private credit, global equities and across the Australian equity market (resources, agriculture, travel and technology).

Read more
Our best ideas are those that we think offer the highest risk-adjusted returns over a 12-month timeframe supported by a higher-than-average level of confidence. They are our most preferred sector exposures.

As interest rates normalise, earnings quality, market positioning and balance sheet strength will play an important role in distinguishing companies from their peers. We think stocks will continue to diverge in performance at the market and sector level, and investors need to take a more active approach than usual to manage portfolios.

Additions: This month we add Elders.

July best ideas

Elders (ELD)

Small cap | Food/Ag

ELD is one of Australia’s leading agribusinesses. It has an iconic brand, 185 years of history and a national distribution network throughout Australia. With the outlook for FY25 looking more positive and many growth projects in place to drive strong earnings growth over the next few years, ELD is a key pick for us. It is also trading on undemanding multiples and offers an attractive dividend yield.

Technology One (TNE)

Small cap | Technology

TNE is an Enterprise Resource Planning (aka Accounting) company. It’s one of the highest quality companies on the ASX with an impressive ROE, nearly $200m of net cash and a 30-year history of growing its earnings by ~15% and its dividend ~10% per annum. As a result of its impeccable track record TNE trades on high PE. With earnings growth looking likely to accelerate towards 20% pa, we think TNE’s trading multiple is likely to expand from here.

ALS Limited

Small cap | Industrials

ALQ is the dominant global leader in geochemistry testing (>50% market share), which is highly cash generative and has little chance of being competed away. Looking forward, ALQ looks poised to benefit from margin recovery in Life Sciences, as well as a cyclical volume recovery in Commodities (exploration). Timing around the latter is less certain, though our analysis suggests this may not be too far away (3-12 months). All the while, gold and copper prices - the key lead indicators for exploration - are gathering pace.

Clearview Wealth

Small cap | Financial Services

CVW is a challenger brand in the Australian retail life insurance market (market size = ~A$10bn of in-force premiums). CVW sees its key points of differentiation as its: 1) reliable/trusted brand; 2) operational excellence (in product development, underwriting and claims management); and 3) diversified distributing network. CVW's significant multiyear Business Transformation Program has, in our view, shown clear signs of driving improved growth and profitability in recent years. We expect further benefits to flow from this program in the near term, and we see CVW's FY26 key business targets as achievable. With a robust balance sheet, and with our expectations for ~21% EPS CAGR over the next three years, we see CVW's current ~11x FY25F PE multiple as undemanding.

GUD Holdings

Large cap | Consumer Discretionary

GUD is a high-quality business with an entrenched market position in its core operations and deep growth opportunities in new markets. We view GUD’s investment case as compelling, a robust earnings base of predominantly non-discretionary products, structural industry tailwinds supporting organic growth and ongoing accretive M&A optionality. We view the ~12x multiple as undemanding given the resilient earnings and long-duration growth outlook for the business ahead.

Stanmore Resources

Small cap | Metals & Mining

SMR’s assets offer long-life cashflow leverage at solid margins to the resilient outlook for steelmaking coal prices. We’re strong believers that physical coal markets will see future cycles of “super-pricing” well above consensus expectations, supporting further periods of elevated cash flows and shareholder returns. We like SMR’s ability to pay sustainable dividends and its inventory of organic growth options into the medium term, with meaningful synergies, and which look under-recognised by the market. We see SMR as the default ASX-listed producer for pure met coal exposure. We maintain an Add and see compelling value with SMR trading at less than 0.8x P/NPV.


Morgans clients receive full access of the Best Ideas, including our large, mid and small-cap key stock picks.

      
Contact us
      
Read more
There are many reasons to invest in equities. Historically, they have offered higher capital returns than many other asset classes. Furthermore, they provide liquidity and diversification and allow investors to participate in the growth of high performing businesses and sectors.

There are many reasons to invest in equities. Historically, they have offered higher capital returns than many other asset classes. Furthermore, they provide liquidity and diversification and allow investors to participate in the growth of high performing businesses and sectors. Not to be overlooked, however, is their capacity to provide an income stream through regular dividends. In the Month Ahead for July, we highlight a selection of Australian equities that offer superior forecast dividend yields and may be suitable investments for those seeking income.

Happy New Financial Year!

BHP Group (BHP)

BHP Group (ASX: BHP) is the largest diversified mining company in the world. BHP has extensive iron ore, copper, nickel and coal operations, and will soon add potash to its portfolio once its massive Jansen project comes online in late 2026. Besides nickel, which has proven volatile, the rest of BHP’s basket of market exposures share the similar characteristic of typically boasting bumper margins throughout the cycle. Over the last decade BHP has shifted its corporate strategy toward streamlining its business, protecting its balance sheet, slowing its pace of investment and maximising shareholder returns. Despite an impressive shareholder performance over recent years, BHP’s dividend yield has remained above market.

      
BHP coverage report
      

Dalrymple Bay Infrastructure (DBI)

Dalrymple Bay Infrastructure (ASX: DBI). DBI owns a fully contracted coal export terminal in central Qld. It has strong revenue and cost risk mitigants, CPI-linked base revenues boosted by incremental revenues from commissioned sustaining capex projects, very high EBITDA margins, and an investment grade credit profile. Investors comfortable with the coal-related exposure also benefit from the ESG discount imputed into the stock price.

      
DBI coverage report
      

Ventia Services Group (VNT)

Ventia Services Group (ASX: VNT) delivers essential services predominantly to government (c.75% of revenue), with an average contract tenure of c.5-7 years and direct inflation passthrough (95% of revenue) in most contracts. The industry grows at 6-7% pa, with VNT growing 7-10% through industry growth and contract expansion, whilst margins should remain stable. The stock continues to deliver a strong dividend yield, which we expect to continue growing at mid-single digits, whilst trading on an undemanding low double-digit PER.

      
VNT coverage report
      

Eagers Automotive (APE)

Eagers Automotive Limited (ASX: APE) is the leading automotive retail group in Australia and New Zealand, operating for over 100 years and representing a diverse portfolio of OEM (original equipment manufacturer) brands. While current industry dynamics in the auto sector (margin pressure; cost of living impacts) are expected to persist in the near-term, we view the scale operators (such as APE) as best placed to navigate this challenging dynamic. Longer-term, we are positive on APE’s various strategic initiatives and expect it can continue to scale; and sustain a structurally higher return on sales through the cycle.

      
APE research report
      

GQG Partners (GQG)

GQG Partners (ASX: GQG) is global asset management boutique, managing ~US$150bn in funds across four primary equity strategies. We like GQG given its highly effective distribution, scalable strategies, and strong long-term investment performance. We view the earnings tailwind from strong funds under management growth (a combination of investment performance and net fund inflows) will continue and we think GQG will continue to re-rate along with this to a higher earnings multiple in time.

      
GQG research report
      

HomeCo Daily Needs REIT (HDN)

HomeCo Daily Needs REIT (ASX: HDN) has a +$4.5bn real estate portfolio focused on daily needs retail (Large Format Retail; Neighbourhood; and Health Services) across +50 properties with the top five tenants being Woolworths, Coles, JB Hi-Fi, Bunnings and Spotlight. Most of leases are fixed. The portfolio has resilient cashflows, with the majority of tenants being national. Sites are in strategic locations with strong population growth. HDN offers an attractive distribution yield, with a +$600m development pipeline providing further growth.

      
HDN research report
      

IPH Limited (IPH)

IPH Limited (ASX: IPH) is a prominent IP services group with market leading shares in Australia, Singapore and Canada. A defensive business, IPH has strong cash flow generation (with high conversion to EBITDA) and a long-track record of paying dividends to shareholders. We like IPH and consider the return to organic growth (albeit subdued) as a key near-term catalyst for the group. Longer-term, we expect IPH to continue to prosecute its consolidation and network expansion strategy offshore.

      
IPH research report
      

Suncorp (SUN)

Suncorp (ASX: SUN) is well positioned to benefit from continued strong price increases going through the home and motor insurance market in Australia, we expect these price increases to be supportive of SUN’s margins expanding further over the next couple of years. Additionally SUN’s recent divestment of its bank was done at an excellent price and will allow the company to focus completely on its strongest business, general insurance, where it is a market leader.  Finally, post the bank sale, SUN now has >A$4bn of excess capital to return to shareholders, which will occur most likely via the way of a share consolidation and a small special dividend.

      
SUN research report
      

Super Retail Group (SUL)

Super Retail Group (ASX: SUL) is a large discretionary retailer comprising four well-known brands which span several categories, including: Supercheap Auto; rebel Sport; Boating, Camping and Fishing (BCF), and Macpac. We like SUL given its market leading scale (>740 stores), deep data capabilities, strong loyalty base and diversified portfolio of brands. SUL has a very strong net cash balance sheet, and we expect it is positioned for further capital management initiatives in the near-term (i.e. potential special dividends).

      
SUL research report
      

Woodside Energy (WDS)

Woodside Energy (ASX: WDS) is the largest ASX-listed oil and gas producer, and in the top 10 globally. While its share price has come under pressure, Woodside’s fundamentals have benefited from resilient oil/LNG prices, steady group production, progress on delivering its key growth projects, a robust level of profitability, and clear focus on its dividend profile. Woodside’s dividend payout ratio has averaged 80% of earnings for the last +5 years, which is impressive given the last 2 years have been a capex-heavy phase as its progressed construction of the Scarborough, Pluto Train 2, and Sangomar projects. With gearing remaining low and cash flow set to grow post the current investment phase, we see Woodside as likely to remain an attractive yield play.

      
WDS research report
      

Morgans clients receive exclusive insights such as access to the latest stock and sector coverage featured in the Month Ahead. Contact us today to begin your journey with Morgans.

      
Contact Us
      
Read more